N Seewald

SA41 REAL-WORLD FRONT-LINE USE OF ENFORTUMAB VEDOTIN - PEMBROLIZUMAB (EV+P) AFTER ADJUVANT NIVOLUMAB IN ADVANCED UROTHELIAL CANCER(AUC)

M Mayer, Aram Babcock, Blanca Homet Moreno, Chethan Ramamurthy et autres

Evaluation of the impact of GLP-1 receptor agonists (RAs) on stage of PDAC diagnosis: A retrospective matched cohort study.

Sean O'Connor, N Seewald, William J. Chapin, Abigail Doucette et autres

e16462 Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy that is most frequently diagnosed at either the locally advanced or metastatic setting. Most patients will not have the opportunity for curative-intent surgical resection. The early symptoms of pancreatic cancer, including weight …

us (code pays fourni par la source)

Untreated advanced urothelial carcinoma (aUC) in the modern treatment era: Patterns of care from a decade-long national cohort.

M Mayer, N Seewald, Aram Babcock, Blanca Homet Moreno et autres

4570 Background: Over the past decade, the therapeutic landscape for locally advanced/unresectable and de novo metastatic urothelial cancer (aUC) has transformed with the introduction of immune checkpoint inhibitors (ICIs) and antibody-drug conjugates (ADCs). These agents offer a more favorable benefit-risk and superior …

us (code pays fourni par la source)

A100-06 Contextual Factors Influencing the Effectiveness of Multilevel Strategies on Annual Lung Cancer Screening and Diagnostic Follow-up

A M Montgomery, A Vachani, C Saia, J Kalman et autres

Abstract Rationale Adherence to annual lung cancer screening (LCS) remains low and inequitable across the U.S., highlighting the critical need to develop effective strategies to ensure LCS benefits are translated into practice. As part of a larger pragmatic trial, this study sought …

us (code pays fourni par la source)

A100-05 Effectiveness of Patient and Clinician Strategies on Increasing Adherence to Annual Lung Cancer Screening and Diagnostic Surveillance: A Pragmatic Factorial Trial

K A Rendle, S Zeb, J Steltz, C Saia et autres

Abstract Rationale Timely completion of annual low-dose CT (LDCT) and diagnostic surveillance is essential to ensure that the potential benefits of lung cancer screening (LCS) are achieved in practice. However, LCS adherence remains remarkably low and inequitable in the US, highlighting the …

us (code pays fourni par la source)